In Vitro Antibacterial Activity of the Ceftazidime-Avibactam (NXL104) Combination against Pseudomonas aeruginosa Clinical Isolates

The β-lactamase inhibitor avibactam (NXL104) displays potent inhibition of both class A and C enzymes. The in vitro antibacterial activity of the combination ceftazidime-avibactam was evaluated against a clinical panel of Pseudomonas aeruginosa isolates. Avibactam offered efficient protection from h...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Levasseur, Premavathy, Girard, Anne-Marie, Claudon, Monique, Goossens, Herman, Black, Michael T., Coleman, Kenneth, Miossec, Christine
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2012
Aiheet:
Susceptibility
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3294935/
https://ncbi.nlm.nih.gov/pubmed/22214778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.06064-11
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia